This Big Coronavirus Stock Offers Investors the Best Bang for the Buck
Let's face it: The shares of many companies with coronavirus programs are priced at nosebleed levels. Investors have flocked to several small stocks with promising experimental COVID-19 therapies or SARS-CoV-2 vaccine candidates.
The picture isn't quite as bad among large-cap companies working on the coronavirus problem. Even among those, though, valuations can be high. But there's one big coronavirus stock that gives you the best bang for the buck by far. That stock is none other than Gilead Sciences (NASDAQ: GILD).
Image source: Getty Images.
Source Fool.com
